中国医药：公司凭借在绿色运营体系构建、社会价值创新创造及公司治理效能提升等维度的综合实力，评级跃升至A级

Core Insights - China Medical (600056) announced on November 5 that it has achieved an upgrade to an A-level rating based on its 2025 Environmental, Social, and Governance (ESG) assessment [1] Group 1 - The company has improved its ESG rating due to its strengths in building a green operation system, creating social value, and enhancing corporate governance effectiveness [1]